Back

Clinical Validation and Machine Learning Optimization of MyCog: A Self-Administered Cognitive Screener

Young, S. R.; Shono, Y.; Hauner, K.; Dworak, E. M.; Mansolf, M.; Curtis, L.; Benavente, J. Y.; Batio, S.; Gershon, R. C.; Wolf, M. S.; Nowinski, C. J.

2025-04-19 primary care research
10.1101/2025.04.17.25325948
Show abstract

BACKGROUNDPrimary care presents an ideal opportunity for early detection of cognitive impairment, yet primary care clinics face barriers to cognitive screening. MyCog, an EHR-integrated tablet app that is self-administered during the rooming process of a primary care visit, streamlines the screening process to reduce barriers and encourage broader screening. METHODSWe compared MyCog performance from 65 adults with diagnosed cognitive impairment to 80 cognitively normal adults, all aged 65+, recruited from clinical settings. We leveraged the consensus of five machine learning models (LASSO, Elastic Net, Random Forest, Bayesian Logistic Regression, and Gradient Boosting) to select consistently discriminative variables for the final detection algorithm. Performance was assessed at for two evidence-based thresholds (Youdens J and Top Left) with ROC AUC, sensitivity, specificity, and accuracy as the primary metrics. RESULTSAll five models showed strong diagnostic performance, with ROC AUC values ranging from 0.839 to 0.876. The consensus modeling approach consistently identified the MyCog Picture Sequence Memory (PSM) exact match score and the MyCog Dimensional Change Card Sort (DCCS) overall rate-correct score as predictors of cognitive impairment. The final logistic regression achieved a robust AUC of 0.890. Depending on the cut point selected, sensitivity ranged from 0.723-0.785 (95% CI: 0.547-0.877), specificity 0.825-0.912 (95% CI: 0.716-0.954), accuracy 0.807-0.828 (95% CI: 0.731-0.869). DISCUSSIONMyCog provides practical, accurate cognitive screening for primary care. The sub-7-minute self-administered assessment eliminates staffing requirements and automates evaluation, addressing screening barriers to facilitate earlier detection and improve clinical outcomes. The algorithms robust performance and parsimony demonstrate clinical utility while maintaining diagnostic accuracy.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
based on 28 papers
Top 0.1%
22.7%
2
Journal of Alzheimer’s Disease
based on 23 papers
Top 0.1%
12.7%
3
Journal of Medical Internet Research
based on 81 papers
Top 2%
7.3%
4
PLOS ONE
based on 1737 papers
Top 64%
6.0%
5
Journal of General Internal Medicine
based on 19 papers
Top 0.4%
5.1%
50% of probability mass above
6
npj Digital Medicine
based on 85 papers
Top 4%
5.1%
7
BMJ Open
based on 553 papers
Top 26%
3.4%
8
Journal of Alzheimer's Disease
based on 31 papers
Top 2%
3.4%
9
Frontiers in Neurology
based on 74 papers
Top 5%
3.2%
10
The Lancet Digital Health
based on 25 papers
Top 0.8%
2.6%
11
Alzheimer's & Dementia
based on 84 papers
Top 4%
1.8%
12
Advanced Science
based on 12 papers
Top 0.7%
1.5%
13
JMIRx Med
based on 29 papers
Top 3%
1.5%
14
British Journal of General Practice
based on 22 papers
Top 1.0%
1.5%
15
PLOS Medicine
based on 95 papers
Top 13%
0.9%
16
F1000Research
based on 28 papers
Top 5%
0.8%
17
BJGP Open
based on 12 papers
Top 2%
0.8%
18
Scientific Reports
based on 701 papers
Top 85%
0.8%
19
JAMA
based on 17 papers
Top 1%
0.8%
20
JAMA Network Open
based on 125 papers
Top 19%
0.8%
21
Journal of Sleep Research
based on 14 papers
Top 1%
0.8%
22
The Lancet Infectious Diseases
based on 57 papers
Top 7%
0.8%
23
Alzheimer's & Dementia: Translational Research & Clinical Interventions
based on 13 papers
Top 2%
0.5%
24
Communications Medicine
based on 63 papers
Top 5%
0.5%
25
BMC Medicine
based on 155 papers
Top 27%
0.5%